StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by AngelMan92on Jul 08, 2020 10:45am

71 Views

Post# 31239056

RE:RE:RE:RE:RE:RE:Wall

The way I understand it is that a wall is the bid/ask that keeps the price from budging a certain direction. For example, when the 4.7 million dump at 55 happened here, the stock didn't drop lower than five because a wall was set at 5 by an ask volume of about 9 million daily. So it just went back and forth until the ask was depleted and now the stock can rise again

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta